Patents by Inventor Junichiro SONODA

Junichiro SONODA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FGFR1 AGONISTS AND METHODS OF USE
    Publication number: 20150376283
    Abstract: The invention provides FGFR1 agonists, including agonistic anti-FGFR1 antibodies, and methods of using the same.
    Type: Application
    Filed: June 29, 2015
    Publication date: December 31, 2015
    Applicant: GENENTECH, INC.
    Inventors: Junichiro Sonoda, Yan Wu
  • ANTIBODIES AND METHODS OF USE
    Publication number: 20150218276
    Abstract: The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the present disclosure includes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an epitope present on KLB.
    Type: Application
    Filed: December 23, 2014
    Publication date: August 6, 2015
    Applicant: GENENTECH, INC.
    Inventors: Yongmei Chen, James Ernst, Hok Seon Kim, Junichiro Sonoda, Christoph Spiess, Scott Stawicki, Yan Wu
  • FGFR1 agonists and methods of use
    Patent number: 9085626
    Abstract: The invention provides FGFR1 agonists, including agonistic anti-FGFR1 antibodies, and methods of using the same.
    Type: Grant
    Filed: May 15, 2012
    Date of Patent: July 21, 2015
    Assignee: Genentech, Inc.
    Inventors: Junichiro Sonoda, Yan Wu
  • CHIMERIC FIBROBLAST GROWTH FACTORS WITH ALTERED RECEPTOR SPECIFICITY
    Publication number: 20140148388
    Abstract: The present invention is directed to novel chimeric fibroblast growth factor (FGF) polypeptides, novel DNA encoding chimeric FGF polypeptides, and to the recombinant production of chimeric FGF polypeptides, and to methods, compositions and assays utilizing chimeric FGF polypeptides for the therapeutic treatment of metabolic-related disorders and other conditions, and for producing pharmaceutically active compositions including chimeric FGF polypeptides, the compositions having therapeutic and pharmacologic properties including those associated with the treatment of metabolic-related disorders and other conditions.
    Type: Application
    Filed: August 7, 2013
    Publication date: May 29, 2014
    Applicant: GENENTECH, INC.
    Inventor: Junichiro SONODA
  • Chimeric fibroblast growth factors with altered receptor specificity
    Patent number: 8535912
    Abstract: The present invention is directed to novel chimeric fibroblast growth factor (FGF) polypeptides, novel DNA encoding chimeric FGF polypeptides, and to the recombinant production of chimeric FGF polypeptides, and to methods, compositions and assays utilizing chimeric FGF polypeptides for the therapeutic treatment of metabolic-related disorders and other conditions, and for producing pharmaceutically active compositions including chimeric FGF polypeptides, the compositions having therapeutic and pharmacologic properties including those associated with the treatment of metabolic-related disorders and other conditions.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: September 17, 2013
    Assignee: Genentech, Inc.
    Inventor: Junichiro Sonoda
  • FGFR1 AGONISTS AND METHODS OF USE
    Publication number: 20120294861
    Abstract: The invention provides FGFR1 agonists, including agonistic anti-FGFR1 antibodies, and methods of using the same.
    Type: Application
    Filed: May 15, 2012
    Publication date: November 22, 2012
    Applicant: Genentech, Inc.
    Inventors: Junichiro Sonoda, Yan Wu
  • CHIMERIC FIBROBLAST GROWTH FACTORS WITH ALTERED RECEPTOR SPECIFICITY
    Publication number: 20110104152
    Abstract: The present invention is directed to novel chimeric fibroblast growth factor (FGF) polypeptides, novel DNA encoding chimeric FGF polypeptides, and to the recombinant production of chimeric FGF polypeptides, and to methods, compositions and assays utilizing chimeric FGF polypeptides for the therapeutic treatment of metabolic-related disorders and other conditions, and for producing pharmaceutically active compositions including chimeric FGF polypeptides, the compositions having therapeutic and pharmacologic properties including those associated with the treatment of metabolic-related disorders and other conditions.
    Type: Application
    Filed: October 15, 2010
    Publication date: May 5, 2011
    Inventor: Junichiro SONODA